NEJM Journal Watch - General Medicine

Anticoagulation appeared to be beneficial in a subgroup with past strokes or transient ischemic attacks.

Treating male partners with two drugs halved the recurrence rate.

A changing legal standard has given the nod to evidence-based practice.

Two more monoclonal antibodies that are not yet approved by the U.S. FDA show promise.

Preliminary data show that both vaccines protected against infection and hospitalization.

Although nonsystemic disease, proximal findings, and autonomic involvement were more characteristic of microvasculitis, there was substantial overlap in this large retrospective cohort.

Disease activity was lower in patients with clinically isolated syndrome who received vitamin D treatment versus placebo.

The incidence of sudden cardiac arrest during races has remained stable, but postarrest survival has improved substantially.

In HIV and ID Observations, Dr. Paul Sax discusses the approval of a brand new antibiotic class for treatment of uncomplicated urinary tract infections.

A new guideline recommends short duration of DAPT if bleeding risk is high and advises bivalirudin instead of heparin for PCI.